DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Analyzing the Global Biosimilars Industry 2016" report to their offering.
Moving to the analysis of the global biosimilars industry, we analyze the market value, market size, upcoming patent expiries for branded biologics and the operating margins of biosimilar manufacturers. Market concerns regarding biosimilars is also included.
Factors driving the market for biosimilars, challenges and impacts on the industry, and industry growth factors, are all analyzed in this in-depth report.
We also take a look at the biosimilar market in developed markets and BRIC countries. Approval pathways and regulatory frameworks in the US, Europe, and Japan are analyzed, along with a comparison of European versus US legislation.
For companies wanting to enter the global biosimilars market, we carry out a market entry analysis through our section K of the report, Entering the Global Biosimilar Industry.
An analysis of Epoetin, Filgrastim, and Somatropin - the major biosimilars - is carried out, along with a look at the emerging opportunities for biosimilars due to the upcoming patent expiries.
The response of Big Pharma against the rise of biosimilars is detailed, followed by an analysis of the major markets and major industry players.
An industry forecast for the global biosimilars industry concludes our comprehensive and cutting-edge analysis of the Global Biosimilars Industry.
Key Topics Covered:
A. Executive Summary
B. Introduction to Biosimilars
C. Introduction to the Biopharmaceutical Industry
D. Analysis of the Global Biosimilars Industry
E. Industry Drivers & Challenges
F. Biosimilar Industry in Developed Markets
G. Biosimilars Industry in BRIC Countries
H. Approval Pathways & Regulatory Framework
I. Entering the Global Biosimilar Industry
J. Competition in the Industry
K. Analyzing Major Biosimilars
L. Opportunities for Biosimilars with the Patent Expiries
M. Big Pharma Responds to Biosimilar Threat
N. Biosimilar Market Analysis
O. Analyzing the Major Players
P. Future Perspective: Global Biosimilars Industry
Q. Glossary
Companies Mentioned
- 3SBio Inc.
- Biocon Limited
- Biopartners Gmbh
- Celltrion Inc.
- Dr. Reddy's Laboratories Limited
- Hospira Inc.
- Intas Biopharmaceuticals
- Kyowa Hakko Kirin Co., Ltd.
- Reliance Life Sciences
- Sandoz International
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd
- STADA Arzneimittel AG
- Teva Pharmaceutical Industries
- Watson Pharmaceuticals
- Wockhardt
For more information visit http://www.researchandmarkets.com/research/pv7jcc/analyzing_the
